An automated analysis of highly complex flow cytometry-based proteomic data

Cytometry Part A

Volumn 81 A, Issue 2, 2012, Pages 120-129

  Stuchlý, Jan ^a,b   Kanderová, Veronika ^a,b   Fišer, Karel ^a,b   Černá, Daniela ^a,b   Holm, Anders ^c   Wu, Weiwei ^c   Hrušák, Ondřej ^a,b   Lund Johansen, Fridtjof ^c   Kalina, Tomáš ^a,b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Bioinformatics; Data analysis; Flow cytometry; Protein array

Indexed keywords

BCR ABL PROTEIN; IMATINIB; MICROSPHERE; PIPERAZINE DERIVATIVE; PROTEOME; PYRIMIDINE DERIVATIVE; TUMOR PROTEIN;

ALGORITHM; ARTICLE; AUTOMATION; COLOR; COMPUTER PROGRAM; FLOW CYTOMETRY; GEL CHROMATOGRAPHY; HUMAN; METABOLISM; METHODOLOGY; PROTEIN DATABASE; PROTEOMICS; QUALITY CONTROL; STANDARD; TIME; TUMOR CELL LINE;

ALGORITHMS; AUTOMATION; CELL LINE, TUMOR; CHROMATOGRAPHY, GEL; COLOR; DATABASES, PROTEIN; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; HUMANS; MICROSPHERES; NEOPLASM PROTEINS; PIPERAZINES; PROTEOME; PROTEOMICS; PYRIMIDINES; QUALITY CONTROL; REFERENCE STANDARDS; SOFTWARE; TIME FACTORS;

EID: 84856223071     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22011     Document Type: Article

References (42)

1. Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: The development and future of multiparameter flow cytometry. Immunology 2008; 125: 441-449.
2. Hsu HY, Joos TO, Koga H. Multiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics-From assays to results. Electrophoresis 2009; 30: 4008-4019.
3. Lugli E, Roederer M, Cossarizza A. Data analysis in flow cytometry: The future just started. Cytometry A 2010; 77A: 705-713.
4. Kalina T, Stuchly J, Janda A, Hrusak O, Ruzickova S, Sediva A, Litzman J, Vlkova M. Profiling of polychromatic flow cytometry data on B-cells reveals patients' clusters in common variable immunodeficiency. Cytometry A 2009; 75A: 902-909.
5. Costa ES, Arroyo ME, Pedreira CE, Garcia-Marcos MA, Tabernero MD, Almeida J, Orfao A. A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorders in peripheral blood samples with absolute lymphocytosis. Leukemia 2006; 20: 1221-1230.
6. Costa ES, Pedreira CE, Barrena S, Lecrevisse Q, Flores J, Quijano S, Almeida J, del Carmen Garcia-Macias M, Bottcher S, Van Dongen JJ, et al. Automated pattern-guided principal component analysis vs. expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: A step forward in the standardization of clinical immunophenotyping. Leukemia 2010; 24: 1927-1933.
7. Pedreira CE, Costa ES, Almeida J, Fernandez C, Quijano S, Flores J, Barrena S, Lecrevisse Q, Van Dongen JJ, Orfao A. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders. Cytometry A 2008; 73A: 1141-1150.
8. Brehme M, Hantschel O, Colinge J, Kaupe I, Planyavsky M, Kocher T, Mechtler K, Bennett KL, Superti-Furga G. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA 2009; 106: 7414-7419.
9. Fontana S, Alessandro R, Barranca M, Giordano M, Corrado C, Zanella-Cleon I, Becchi M, Kohn EC, De Leo G. Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines. J Proteome Res 2007; 6: 4330-4342.
10. Goss VL, Lee KA, Moritz A, Nardone J, Spek EJ, MacNeill J, Rush J, Comb MJ, Polakiewicz RD. A common phosphotyrosine signature for the Bcr-Abl kinase. Blood 2006; 107: 4888-4897.
11. Lee CF, Griffiths S, Rodriguez-Suarez E, Pierce A, Unwin RD, Jaworska E, Evans CA, Gaskell JS, Whetton AD. Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approaches. Proteomics 2010; 10: 3321-3342.
12. Titz B, Low T, Komisopoulou E, Chen SS, Rubbi L, Graeber TG. The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. Oncogene 2010; 29: 5895-5910.
13. Xiong L, Zhang J, Yuan B, Dong X, Jiang X, Wang Y. Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells. J Proteome Res 2010; 9: 6007-6015.
14. Kopf E, Zharhary D. Antibody arrays-An emerging tool in cancer proteomics. Int J Biochem Cell Biol 2007; 39: 1305-17.
15. Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM. Antibody-based proteomics: Fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 2010; 10: 605-617.
16. Wu W, Slastad H, de la Rosa Carrillo D, Frey T, Tjonnfjord G, Boretti E, Aasheim HC, Horejsi V, Lund-Johansen F. Antibody array analysis with label-based detection and resolution of protein size. Mol Cell Proteomics 2009; 8: 245-257.
17. Holm A, Wu W, Lund-Johansen F. Antibody-array analysis of labelled proteomes: How should we control specificity? N Biotechnol 2011, (in press) doi:10.1016/j.nbt.2011.07.008.
18. Gleissner B, Gokbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW, Fonatsch C, Heyll A, Voliotis D, Beck J, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: A prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 2002; 99: 1536-1543.
19. Goldman JM, Melo JV. Chronic myeloid leukemia-Advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451-1464.
20. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL. Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 1987; 70: 948-953.
21. Drexler HG, MacLeod RA, Uphoff CC. Leukemia cell lines: In vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk Res 1999; 23: 207-215.
22. Hazlehurst LA, Bewry NN, Nair RR, Pinilla-Ibarz J. Signaling networks associated with BCR-ABL-dependent transformation. Cancer Control 2009; 16: 100-107.
23. Kanderova V, Hrusak O, Kalina T. Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells. Exp Hematol 2010; 38: 653-660 e1.
24. Montiel-Duarte C, Cordeu L, Agirre X, Roman-Gomez J, Jimenez-Velasco A, Jose-Eneriz ES, Garate L, Andreu EJ, Calasanz MJ, Heiniger A, et al. Resistance to imatinib mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res 2008; 32: 709-716.
25. Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP, Ottmann OG. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: A gene-expression study. Lancet 2002; 359: 481-486.
26. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876-880.
27. von Bubnoff N, Schneller F, Peschel C, Duyster J. BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: A prospective study. Lancet 2002; 359: 487-491.
28. Maechler M, Rousseeuw P, Struyf A, Hubert M. Cluster Analysis Basics and Extensions. 2005,
29. Hahne F, LeMeur N, Brinkman RR, Ellis B, Haaland P, Sarkar D, Spidlen J, Strain E, Gentleman R. flowCore: A Bioconductor package for high throughput flow cytometry. BMC Bioinformatics 2009; 10: 106.
30. Douglas B, Martin M. Matrix: Sparse and Dense Matrix Classes and Methods. Version 0.999375-50. 2011,
31. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal 2006; Complex Systems: 1695.
32. Lang DT, Swayne D, Wickham H, Lawrence M. rggobi: Interface Between R and GGobi. R Package Version 2.1.14. 2009,
33. Wickham H. Reshaping data with the reshape package. J Stat Software 2007; 21:1-20
34. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2009.
35. Kaufmann L, Rousseeuw PJ. Finding Groups in Data: An Introduction to Cluster Analysis. New York: Wiley; 1990.
36. Nolan JP, Mandy F. Multiplexed and microparticle-based analyses: Quantitative tools for the large-scale analysis of biological systems. Cytometry A 2006; 69A: 318-325.
37. Davey HM. Prospects for the automation of analysis and interpretation of flow cytometric data. Cytometry A 2010; 77A: 3-5.
38. Finn WG, Carter KM, Raich R, Stoolman LM, Hero AO. Analysis of clinical flow cytometric immunophenotyping data by clustering on statistical manifolds: Treating flow cytometry data as high-dimensional objects. Cytometry B Clin Cytom 2008; 76B: 1-7.
39. Klinke DJII, Brundage KM. Scalable analysis of flow cytometry data using R/bioconductor. Cytometry A 2009; 75A: 699-706.
40. Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler DA, et al. Automated high-dimensional flow cytometric data analysis. Proc Natl Acad Sci USA 2009; 106: 8519-8524.
41. van der Kuip H, Goetz AW, Miething C, Duyster J, Aulitzky WE. Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis. Blood 2001; 98: 1532-1541.
42. Oetzel C, Jonuleit T, Gotz A, van der Kuip H, Michels H, Duyster J, Hallek M, Aulitzky WE. The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X. Clin Cancer Res 2000; 6: 1958-1968.